Frazis Capital Partners
Eli Lilly, Curvebeam AI, Syntara, a new approach in Alzheimer's, and Hashan's new fund
Rockets, robots, algos and chips
The first rate cuts, a new scaling vector, and healthcare booms
Misha's new fund, the crash and recovery of early August, and self-driving cars
Flash crash and reporting season
Strategy update
And a raise from Clarity Pharmaceuticals
